Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Caffeic Acid Inhibits Tumour Mass Formation in MG-63 Cells-induced Nude Mice

The Indonesian Biomedical Journal · Vol. 14 No. 4 (2022) · hlm. 416–420

DOI
10.18585/inabj.v14i4.2078
ISSN
2085-3297, 2355-9179
Terbit
2022-12-01
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Formation of tumour mass is one symptom of osteosarcoma development. Caffeic acid has been known to provide effective treatment but has less side effect for some cancer therapy. Studies reported that caffeic acid might promote apoptosis in MG-63 osteosarcoma cells, however, the effect of caffeic acid treatment in preventing tumour mass formation has not been well elucidated, especially in MG-63 cells-induced nude mice in vivo.METHODS: MG-63 cells were pre-treated with 0, 1, or 10 µg/mL caffeic acid, and 6 hours after pre-treatment, MG-63 cells were injected into subcutaneous space of mice to induce osteosarcoma. Another model was also created by subcutaneously injecting MG-63 cells to the back of mice, and after 48 days, the visible tumour mass was injected intra-tumour with 0 or 10 µg/mL caffeic acid every 7 days for 6 times. After 90 days, mice were anaesthetised, and the nodule pictures were taken for observation and measurement. RESULTS: In pre-treated MG-63 cells-induced mice, volumes of the mass decreased in reverse with the dose of caffeic acid given. Ten µg/mL caffeic acid pre-treatment was able to significantly lower the mass volume compared to the untreated (p<0.05). Meanwhile, the intra-tumour treatment of 10 µg/mL caffeic acid, even though not significant, was able to inhibit tumour mass formation.CONCLUSION: Results of caffeic acid pre-treatment and caffeic acid treatment in tumour mass of mice show that caffeic acid is able to inhibit the MG-63 cells formation. This suggests that caffeic acid can be a potential anti-cancer agent.KEYWORDS: caffeic acid, osteosarcoma, MG-63 cells, tumour mass

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 102 tautan kepenulisan bersama · 57 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Trisakti
  • University of Brawijaya
  • Universitas Airlangga
  • Padjadjaran University
  • Hasanuddin University
  • University of Indonesia
  • PT Prodia StemCell Indonesia (Indonesia)
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Andi WijayaHasanuddin University47
Anna MeilianaPadjadjaran University45
Johni HalimUniversitas Trisakti8
Muhammad Ihsan RizalUniversitas Trisakti6
Angliana ChouwPT Prodia StemCell Indonesia (Indonesia)6
Visi Endah PratitisAfiliasi tidak diketahui6
Janti SudionoUniversitas Trisakti5
Alifah Evi ScaniaUniversity of Indonesia5
Kyung Hoon LeeAfiliasi tidak diketahui5
Solachuddin Jauhari Arief IchwanUniversiti Brunei Darussalam5
Djanggan SargowoUniversity of Brawijaya4
Yanni DirgantaraPT Prodia StemCell Indonesia (Indonesia)4
Maria CelinnaAfiliasi tidak diketahui4
Toshio KukitaKyushu University4
Wahyu WidowatiMaranatha Christian University3
Roya Khosravi‐FarBeth Israel Deaconess Medical Center3
Irawan YusufHasanuddin University3
Boedi Oetomo RoeslanUniversitas Trisakti3
Ketherin KetherinUniversitas Trisakti2
Tjandrawati MozefIndonesian Institute of Sciences2
Ardian RizalUniversity of Brawijaya2
Irma Ruslina DefiPadjadjaran University2
Tadahiko IijimaKyushu University2
Sonar Soni PanigoroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Herqutanto HerqutantoUniversity of Indonesia2
Andon HestiantoroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Nyoman Suci WidyastitiDiponegoro University2
Pudji RahajuUniversity of Brawijaya2
Ahmad Dian WahyudionoUniversity of Brawijaya2
Reza Gunadi RanuhUniversitas Airlangga2
Alpha Fardah AthiyyahUniversitas Airlangga2
Andy DarmaUniversitas Airlangga2
Subijanto Marto SudarmoUniversitas Airlangga2
Bambang SutrisnaUniversity of Indonesia2
Mansyur ArifHasanuddin University2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Caffeic Acid Inhibits Tumour Mass Formation in MG-63 Cells-induced Nude Mice</dc:title><dc:creator>Ferry Sandra</dc:creator><dc:creator>Dewi Ranggaini</dc:creator><dc:creator>Laifa Annisa Hendarmin</dc:creator><dc:creator>Nurrani Mustika Dewi</dc:creator><dc:creator>Melanie Sadono Djamil</dc:creator><dc:subject>caffeic acid</dc:subject><dc:subject>osteosarcoma</dc:subject><dc:subject>MG-63 cells</dc:subject><dc:subject>anticancer agents</dc:subject><dc:subject>pretreatment</dc:subject><dc:subject>nude mouse xenograft</dc:subject><dc:subject>tumor growth inhibition</dc:subject><dc:description xml:lang="en">BACKGROUND: Formation of tumour mass is one symptom of osteosarcoma development. Caffeic acid has been known to provide effective treatment but has less side effect for some cancer therapy. Studies reported that caffeic acid might promote apoptosis in MG-63 osteosarcoma cells, however, the effect of caffeic acid treatment in preventing tumour mass formation has not been well elucidated, especially in MG-63 cells-induced nude mice in vivo.METHODS: MG-63 cells were pre-treated with 0, 1, or 10 µg/mL caffeic acid, and 6 hours after pre-treatment, MG-63 cells were injected into subcutaneous space of mice to induce osteosarcoma. Another model was also created by subcutaneously injecting MG-63 cells to the back of mice, and after 48 days, the visible tumour mass was injected intra-tumour with 0 or 10 µg/mL caffeic acid every 7 days for 6 times. After 90 days, mice were anaesthetised, and the nodule pictures were taken for observation and measurement. RESULTS: In pre-treated MG-63 cells-induced mice, volumes of the mass decreased in reverse with the dose of caffeic acid given. Ten µg/mL caffeic acid pre-treatment was able to significantly lower the mass volume compared to the untreated (p&lt;0.05). Meanwhile, the intra-tumour treatment of 10 µg/mL caffeic acid, even though not significant, was able to inhibit tumour mass formation.CONCLUSION: Results of caffeic acid pre-treatment and caffeic acid treatment in tumour mass of mice show that caffeic acid is able to inhibit the MG-63 cells formation. This suggests that caffeic acid can be a potential anti-cancer agent.KEYWORDS: caffeic acid, osteosarcoma, MG-63 cells, tumour mass</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2022-12-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v14i4.2078</dc:identifier><dc:identifier>10.18585/inabj.v14i4.2078</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 14 No 4 (2022); 416-420</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/2078/612</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>